PetMed Express (Nasdaq: PETS) reported earnings on May 6. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q4), PetMed Express missed estimates on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue dropped. GAAP earnings per share grew significantly.

Margins grew across the board.

Revenue details
 PetMed Express booked revenue of $51.1 million. The seven analysts polled by S&P Capital IQ expected a top line of $55.3 million on the same basis. GAAP reported sales were 8.6% lower than the prior-year quarter's $55.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.23. The seven earnings estimates compiled by S&P Capital IQ anticipated $0.21 per share. GAAP EPS of $0.23 for Q4 were 21% higher than the prior-year quarter's $0.19 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 35.7%, 180 basis points better than the prior-year quarter. Operating margin was 14.2%, 300 basis points better than the prior-year quarter. Net margin was 9.0%, 190 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $69.8 million. On the bottom line, the average EPS estimate is $0.21.

Next year's average estimate for revenue is $234.1 million. The average EPS estimate is $0.85.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 867 members out of 895 rating the stock outperform, and 28 members rating it underperform. Among 216 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 212 give PetMed Express a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PetMed Express is hold, with an average price target of $11.92.

Can your portfolio provide you with enough income to last through retirement? You'll need more than PetMed Express. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.